Anne-Frederique Naviaux is a consultant Psychiatrist and Child Psychiatrist, who finished her Master in Psychiatry in 2004 (Universite Catholique de Louvain, Belgium). She worked in France as a ‘praticien hospitalier’ in Child Psychiatry and for the World Health Organization, before joining the research department in Trinity College (Dublin, Ireland) in 2011. She has been a lecturer in France (IFSI) since 2004 but has also joined the Royal College of Surgeons of Ireland in 2012. She currently works for the Health Service Executive in Ireland as Head of Service in Summerhill Adult Mental Health Centre (Wexford) and as Clinical Lead for Liaison Psychiatry in Wexford General Hospital (WGH). Since 2016, she has been developing in collaboration with the Paediatric Team in WGH, an out of hours emergency service for young people with Mental Health Issues.
Background: At the cross-roads of feeding and eating disorders, avoidant/restrictive food Intake disorder (ARFID) is sometimes used as an “umbrella diagnosis” as it covers a certainly large and rather heterogeneous list of eating symptoms. It appeared in the DSM5 in 2013, but still, there are no clear guidelines for both diagnosis and treatment.
Purpose: Review and synthetize the latest publications on ARFID as a relatively new and emerging diagnostic category and regarding the current pharmacological management/treatment options.
Subjects and Methods: Between March 2018 and May 2019, a literature search based on electronic bibliographic databases as well as other sources of information (grey literature) was conducted in order to investigate the current ARFID characteristic and treatment modalities, especially regarding medication.
Results: ARFID patients have some identified characteristics that separate them from other patients with other eating disorders. Multiple molecules have been successfully tried in the ARFID management, usually in combination with at least one psycho-dynamic approach and various models of care.
Conclusion: This research offers the opportunity to discuss how to currently diagnose and manage this newly identified condition, and more specifically the different pharmacological molecules that have been helpful for young patients with ARFID.
Suhas Machhindra Gaikwad is the Research Coordinator at Christ (Deemed to be University) Lavasa Pune India. He has been awarded a certificate as an international best scientist at New Delhi at a conference held on 18th and 19th January 2020 by VDGOOD. the award was given for his contribution in the medical field for diabetic and heart patients in System Dynamics AHP, Optimization.
Coronary Angiography bypass sugary is meant for removing blockage in the coronary arteries of heart. Removing blockage from the heart with Coronary Angiography leads to the regulation of the blood flow rate at normal pressure. However, after a few years of the Coronary Angiography bypass sugary nearly fifty percent of people will develop again a blockage in the coronary arteries. Although, the Medical Science and Technology advanced so much there is a lack of an Optimization tool that handles complications of the Coronary Angiography bypass sugary. A new Optimization tool using Genetic Algorithm with the Coronary Angiography bypass sugary GA-CABAG, and Cohort Intelligence, Coronary Angiography bypass surgery CI –CABAG is introduced to help to resolve the above-mentioned problem.
Dr Hudson is a Clinical Associate Professor at the GOS UCL Institute of Child Health, consultant paediatrician at Great Ormond Street Hospital working within the departments of General and Adolescent Paediatrics and Mental Health; and is also Chief Officer for Mental Health Services at Great Ormond Street Hospital. Dr Hudson is section head at the Institute of Child Health for Child and Adolescent Mental Health, Palliative Care and Paediatrics (CHAMPP : https://www.ucl.ac.uk/child-health/research/population-policy-and-practice-research-and-teaching-department/champp-child-and-adolescent) within the division of Population Policy and Practice.
Dr Hudson’s research interests are in underweight and overweight, in particular longer term outcomes of both conditions in children and young people. Dr Hudson is also has a passion for improving the medical care of children and young people with eating disorders and has worked at a local, national and international level with this aim. Dr Hudson is currently the paediatrician on the National Institute of Clinical Excellence (NICE) guidelines for eating disorders, and regularly teaches and trains paediatricians and mental health professionals across the UK to improve care for the physical health of mental health patients.